Reata Pharmaceuticals, Inc. EBITDA Margin 2016-2023 | RETA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Reata Pharmaceuticals, Inc. (RETA) over the last 10 years. The current EBITDA margin for Reata Pharmaceuticals, Inc. as of June 30, 2023 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-06-30 | $0.02B | $-0.36B | -1495.83% |
| 2023-03-31 | $0.00B | $-0.33B | -16400.00% |
| 2022-12-31 | $0.00B | $-0.28B | -9333.33% |
| 2022-09-30 | $0.00B | $-0.27B | -6725.00% |
| 2022-06-30 | $0.01B | $-0.25B | -2540.00% |
| 2022-03-31 | $0.01B | $-0.25B | -2254.55% |
| 2021-12-31 | $0.01B | $-0.24B | -2154.55% |
| 2021-09-30 | $0.01B | $-0.22B | -1684.62% |
| 2021-06-30 | $0.01B | $-0.22B | -3071.43% |
| 2021-03-31 | $0.01B | $-0.20B | -2550.00% |
| 2020-12-31 | $0.01B | $-0.22B | -2725.00% |
| 2020-09-30 | $0.01B | $-0.35B | -4375.00% |
| 2020-06-30 | $0.02B | $-0.34B | -2240.00% |
| 2020-03-31 | $0.02B | $-0.32B | -1610.00% |
| 2019-12-31 | $0.03B | $-0.28B | -1048.15% |
| 2019-09-30 | $0.03B | $-0.12B | -384.38% |
| 2019-06-30 | $0.03B | $-0.11B | -393.10% |
| 2019-03-31 | $0.03B | $-0.11B | -368.97% |
| 2018-12-31 | $0.05B | $-0.08B | -141.51% |
| 2018-09-30 | $0.06B | $-0.07B | -121.82% |
| 2018-06-30 | $0.06B | $-0.05B | -79.37% |
| 2018-03-31 | $0.07B | $-0.04B | -51.47% |
| 2017-12-31 | $0.05B | $-0.05B | -93.88% |
| 2017-09-30 | $0.05B | $-0.03B | -65.38% |
| 2017-06-30 | $0.05B | $-0.02B | -44.23% |
| 2017-03-31 | $0.05B | $-0.01B | -25.49% |
| 2016-12-31 | $0.05B | $-0.01B | -12.00% |
| 2016-09-30 | $0.05B | $-0.00B | -4.00% |
| 2016-06-30 | $0.05B | 0 | 0.00% |
| 2016-03-31 | $0.05B | 0 | 0.00% |
| 2015-12-31 | $0.05B | $0.00B | 1.96% |
